InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,599.60
(
1.04%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.67
(
0.23%
)
Bitcoin
63,570.45
(
0.64%
)
Post# of 10489
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

cdaniel394

Send PM Follow Ignore
Followers 50
Posts 7839
Boards Moderated 0
Alias Born 11/20/2005

cdaniel394

Re: None

Tuesday, 03/21/2017 2:14:33 PM

Tuesday, March 21, 2017 2:14:33 PM

Post# of 10489
http://www.abstractsonline.com/pp8/#!/4292/presentation/12573


CT162 / 28 - Pre-specified interim analysis in a prospective, randomized phase II trial of trastuzumab vs trastuzumab + NeuVax to prevent breast cancer recurrence in HER2+ breast cancer patients
April 3rd
From itsyou on my-gale.com
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up